Uploaded by whis96

Maternity Full Drug Cards (Chart)

advertisement
Generic /Trade
Name
Normal
Dosage
>12 y.o.: 325560 mg PO q 4-6
hr or 1300 mg
PO q 8 hr
Max dose: 4,000
mg/day
Classification
Analgesic
FDA Pregnancy Class:
B
Therapeutic Effects &
Indications
 Inhibit the synthesis of
prostaglandins which
play a role in
transmission of pain
signals and fever
Adverse Effects
12 mg/dose 2x
12 or 24 hours
apart when
used during
pregnancy
Betamethasone
Corticosteroid
FDA Pregnancy Class:
C
 Maternity use:
 For minor aches and
pains associated with
childbirth, labor or
childbirth complication
 Reduction in fever from
minor infections or
illnesses
 Help ease pain from
circumcised infant
 Binds to glucocorticoid
receptors and then
binds to DNA to modify
gene expression
 Causes the release of
surfactant (helping with
lung development)
 Treatment of primary or
secondary
andreocortical
insufficiency
 Short term management
of inflammatory and
allergic disorders
 Management of MS
exacerbations
 Maternity use:
 Single round doses are
given to pregnant
women to help speed
up lung development in
infant when at rish for
delivering prematurely
Teachings




Hepatoxixity/hepatic failure
Myocardial damage
Gastrointestinal bleeding
Adverse effects increase
when mixed with alcohol or
barbiturates.
 Pregnancy/Breastfeeding:
 Safe for women who are currently
pregnant or breastfeeding
 Acetadote is the antidote for
overdose
 May increase risk for bleeding
with warfarin therapy
 Note that it could alter blood
glucose levels
 Assure patient does not mix with
any other acetaminophen
containing drugs.
 Assure that patient knows
risks if mixed with other
acetaminophen containing
meds and provide examples
as to what common meds
are
 Safe with breastfeeding
 Not recommended for use
over 10 continuous days







Aggravation of infection
Headache
Immunosuppression
Increased appetite
Masking of infection
Vertigo
Weight gain
 There is an interaction with live
vaccines
 Make sure patient is wearing alert
tag after administration
 Monitor blood glucose levels
 Caution should be taken when
breastfeeding; excreted through
breastmilk
 Educate on the risk of the
outcome of corticosteroids
that are excreted in
breastmilk from medication
 Educate on the possibility of
growth suppression
 Not recommended for use
over 10 continuous days
 Antipyretic; Temporary
reduces fever
 Temporary relief of
minor aches and pains
Acetaminophen
Nursing Care
Generic /Trade
Name
Normal
Dosage
19-50: 1000
mg/d PO
14-18: 1300
mg/d PO
Classification
Antacid/electrolyte
FDA Pregnancy Class:
C
Calcium
Gluconate
12 y.o.: 50-200
mg/day
Laxative, emollients
FDA Pregnancy Class:
C
 Treatment of
hypocalcemia,
hyperphosphatemia and
magnesium intoxication
disorders
 Management of acid
reflux induced by
pregnancy
 Increases the amount of
water the stool absorbs
in the large intestine
 Treats constipation or
difficult defecation from
fluctuating increase in
hormone levels
 Pressure of the growing
uterus places on the
large intestine
Colace
Cytotec
Therapeutic Effects &
Indications
 Reacts with hydrofluoric
acid to form an
insoluble and non-toxic
form of calcium fluoride
200 mcg 4x daily
with food (to
prevent ulcers)
25-100 mcg for
induction of
labor
200-1000 mcg
for reduction of
PP hemorrhage
Prostaglandin,
gastrointestinal
agents
FDA Pregnancy Class:
X
 Lines walls of stomach
and aids in the
prevention of acid
erosion
 Softens cervix to induce
labor
 Prevent stomach ulcers
caused by NSAID pain
medications
 Used to terminate
pregnancy
 Used to induce labor
 Used to treat PP
hemorrhage
Adverse Effects
Nursing Care
Teachings





Anorexia
Bradycardia
Constipation
Hypercalcemia
Hypotension
 Do not administer other oral
meds within 1-2 hours of giving
antacid
 Monitor serum phosphate
periodically
 Administer between meals and at
bedtime
 Only give med if medically
necessary
 Teach importance of not
taking within 1-2 hours of
other oral meds
o
Drug affects the
absorbtion of medication
 Unknown if passed through
breastmilk






Stomach cramps
Nausea
Diarrhea
Weakness
Sweating
Muscle cramps
 Consider giving, suggesting or
getting doctor approval for use of
colace if mother is experiencing
three or fewer bowel movements
per week
 Mention lifestyle changes in
conjunction or instead of taking a
medication if mother is wary of
taking drugs while pregnant or
breastfeeding
 Decide if colace is the correct
choise and decide on proper
dosage.
 Educate on severity of
symptoms
 Recommend lifestyle
modifications to ease
constipation (i.e. increased
water intake, exercise)
 Explain that colace is safe for
baby if symptom relief is
needed
 Mild to moderate symptoms
may occur until body gets
used to med
 No side effects passed to
baby if used during
breastfeeding









Vaginal bleeding
Nausea
Diarrhea
Weakness
Sweating
Feeling thirsty/hot
Muscle/menstrual cramps
Hyperstimulation of uterus
Uterine rupture
 Start at 25 mg and increase
dosage as labor progresses/closer
gets to delivery
 Monitor mother and baby during
delivery for fetal distress and
extrem contractions
 Recognize that a c-section is
indicated if a dose of 100 mg does
not fully induce labor
 Explain possible side effects
and severity of birth defects
if any of the side effects
occurred
 Clear up misconceptions that
med is used to cause an
abortion when used in lateterm pregnancy as induction
agent
 If used for ulcers, explain risk
of miscarriage and
importance of contraception
use
 Can cause abortion if given too
early in gestation.
 Must have negative pregnancy
test 2 weeks prior to first dose
Generic /Trade
Name
Normal
Dosage
150 mg/mL
Classification
Antineoplastics
FDA Pregnancy Class:
X
 Contraceptive
 Manages conditions
related to your
menstrual cycle
Depo Provera
Dose: IV 4-10
mg diluted over
5 min. SUBQ/IM
5-20 mg Q4 hrs
PRN
Duramorph
Opioid
Agonist/analgesic
Morphine Injection
Controlled schedule
II
FDA Pregnancy Class:
C
Dose: IM; initial
250 mcg (1mL)
Prostaglandin
FDA Pregnancy Class:
C
Hemabate
 Depresses pain impulse
transmission at the
spinal cord level by
interacting with opioid
receptors, produces CNS
depression.
 Pain effects in 10-20 min
last 2-5 hrs
 Use as a last resort.
 Epidural
 Respiratory depression
 Stimulates uterine and
vascular smooth muscle,
causing contraction and
decrease bleeding.
 In pregnancy and
postpartum: Preventing
hemorrhage.
 Induction of midterm
abortion.
Hep B Vaccine
Insulin Regular
Therapeutic Effects &
Indications
 Prevents ovulation for
up to 12 weeks
 Thickens cervical mucus
to prevent sperm from
reaching the egg
Varies per
person
SubQ 0.3-0.7
units/kg/day
Insulin; antidiabetic,
short-acting insulin
Adverse Effects
Nursing Care
Teachings
 Unexplained vaginal
bleeding
 Liver disease
 Breast cancer
 Osteoporosis
 Delay in the return to
fertility
 Abdominal pain
 Bloating
 Weight gain
 Weakness
 Should be given no less than 5
days PP to assure that the patient
is not pregnant before
administration if not
breastfeeding
 If breastfeeding, initial injection
PP should be given no less than 6
weeks after delivery
 Respiratory depression
 C-section effects last for 24
hours
 Pruritus
 Constipation
 Nausea
 Sedation
 Drowsiness
 Dizziness
 anaphylactic reaction
cardiac arrest
 convulsions
 bradycardia.
 Should not be given in the latent
stage due to the effects on the
fetus. Do not give to women with
opioid dependency.
 Explain possible SE/AE and
severity of birth defects if SE
occurred
 Educate Pt on frequency of
injection (every 12 weeks)
 Explain that after 89 days
from last injection, if not
followed by another
pregnancy, to use other
forms of contraception
 Explain the risk of heave and
prolonged bleeding might
occur if injections are started
immediately after delivery or
termination of pregnancy
 No breastfeeding while
taking it because it can be
passed through breastmilk










 Regulates carbohydrate,
fat, and protein
metabolism




Nausea
 Give when fundus is boggy to
contract uterus and provide
Vomiting
increased blood flow.
Diarrhea
 Don’t exceed 12mg or continuous
Numbness
administration for 1mo.
Headache

Should not be given if patient has
menstrual pain
asthma.
fever/chills
uterine laceration rupture or
hemorrhage.
Hypoglycemia
Hematoma
Sinus tachycardia
Headache
 Instruct patient to notify
health care professional if
you experience severe pelvic
pain, cramping, high fever,
light headedness, or
increased blood pressure.


 Monitor and control blood
glucose
 Safe for breastfeeding
 Insulin usually returns to
normal levels after labor
 Follow up 6 weeks PP
Generic /Trade
Name
Normal
Dosage
Classification
FDA Pregnancy Class:
B
Must be
individualized
Intermittent IV
initial 20 mg
over 2 minutes.
Oral: 100mg BID
Antihypertensive
(Beta blocker)
FDA Pregnancy Class:
C
Labetalol
Therapeutic Effects &
Indications
 Promotes storage and
inhibits breakdown of
glucose
 Treats diabetes during
pregnancy
 Combines selective,
competitive, alpha-1
adrenergic blocking and
nonselective,
competitive, betaadrenergic blocking
activity
 Treat high blood
pressure
40 mg PO BID
Diuretic,
antihypertensive
FDA Pregnancy Class:
C
Lasix
Lovenox
40 mg deep
SubQ 2 hrs
before surgery
repeated 24 hrs
after initial does
and continued
daily for 7-10
days
Anticoagulant
FDA Pregnancy Class:
B
 Thought to inhibit
sodium and chloride
reabsorption from loop
of Henle.
 Increase K excretion and
plasma volume
 Promote renal excretion
 Hypertension
 Acute pulmonary edema
 Edema caused by heart
failure
 Hepatic cirrhosis
 Renal disease
 Inhibits thrombus and
clot formation
 Deactivates thrombin
and prevents conversion
of fibrinogen to fibrin
 Deep vein thrombosis
 Preventing clots
Adverse Effects
 Diaphoresis
 Dyspnea (shortness of
breath)
 Hypertension
 Edema
 Weight gain
 Maternal and fetal
tachycardia
 Palpitations
 Cardiac dysrhythmias
 Hypokalemia
 Hyperglycemia
 Chest pain
 Wide pulse pressure
 Dyspnea
 Tremors
 Restlessness
 Weakness
 Dizziness
 Dizziness
 Hypotension
 Tachycardia
 Arrhythmias
 Blurred vision
 Cramping
 Dyspnea
 Dry mouth
 Anorexia










Dizziness
Edema
Confusion
Urinary retention
Anemia
Hyperkalemia
Fever
Bleeding
Atrial Fibrilation
Hemorrhage
Nursing Care
Teachings
 First-line medication for
management of acute-onset,
severe hypertension
 Assess FHR
o >160 should report
 Mother’s HR
o >120
 Respirations
o >24 RR
 Dyspnea
 Systolic BP
o <80-90
 Avoid getting up too fast
 Avoid drinking alcohol
 Crosses the placenta
 Can be given direct of over 1 to 2
minutes
 Don’t infuse more than 4
mg/minute
 IV or IM given for rapid onset
diuresis
 Watch for ototoxicity
 Monitor CO2
 Monitor BP
 Monitor glucose
 Monitor fluid intake and output
 Monitor pulse
 Monitor symptoms of
hypokalemia
 Be aware of Lovenox is a high
alert drug
 Don’t expel air bubble from
syringe before giving
 Don’t give IM or IV
 Use tuberculin syringe with
multidose
 Use cautiously when
breastfeeding or pregnant
 Take in morning with food
 May interact with common
other drugs
 Avoid driving
 Move slowly when getting up
 Avoid alcohol and herbs
 Report irregular heartbeat,
bleeding, or rash
 Avoid bruising
 Weigh themselves regularly
o
Report gains
 Inform dentist of medication
use
Generic /Trade
Name
Magnesium
Sulfate
Normal
Dosage
Dose: 4-6g in
100mL IV over
15-20 min
continuing
infusion 2g/hr
for
preeclampsia.
Classification
Tocolytics
(anticonvulsant)
FDA Pregnancy Class:
D
Methadone
Methergine
1mL (0.2 mg)
IV: administered
slowly over 60
sec
IM: every 2-4
hours
Pharmacologic: Ergot
alkaloid
FDA Pregnancy Class:
C
Morphine
Sulfate
800 mg/dose
Not to exceed
3200 mg/day
NSAID
FDA Pregnancy Class:
D
Adverse Effects
Nursing Care
Teachings




Flushing
Sweating
hypotension
depressed deep tendon
reflexes
 CNS depression (respiratory
depression)
 Monitor for signs and symptoms
of labor progression or worsening
signs/symptoms of preeclampsia
 Avoid using for more than 57 days for preterm labor
 Avoid use during active labor
or within 2 hours of delivery
due to potential for
magnesium toxicity in
neonate




 Stimulates contractions
in uterus, decreases
bleeding postpartum
 Stimulates contractions
in uterus, decreases
bleeding postpartum






Nausea
Vomiting
Stomach pain
Thrombophlebitis
Leg cramps
Diaphoresis (excessive
sweating)
 Dizziness
 Tinnitus
 If taken during third stage of
labor, the risk of hemorrhage and
infection increases
 Should not breastfeed during
treatment involving
Methergine
 Can reduce the production of
breast milk
 Pump and dump for 12 hours
after last dose of Methergine




 Reduces hormones that
cause inflammation and
pain










 Assess for allergies before
administration
 Closely monitor mother and fetus
for AE
 Warn of side effects when
taking pain reducer during
labor
 Inform to report of any AE
after administration
 Consult with provider if
breastfeeding; unknown if
passes in breast milk


 Assess for allergies before
administration
 Assess BP and pulse
 Assess for BP and cardiac rhythm
following administration
 Warn of side effects before
administration
 Inform to report any AE
especially dyspnea
 Used to help manage
pain during labor and PP
Motrin

Narcan
Nifedipine
Therapeutic Effects &
Indications
 It depresses the central
nervous system, acts as
an anticonvulsant, and
decreases frequency
and intensity of uterine
contractions.
 In pregnancy it prevents
and controls seizures
and decreases
frequency and intensity
of uterine contractions.
 Additionally, in smaller
doses it can stop
preterm labor
contractions.
Initial dose: 20
mg PO
20 mg every 3-8
hrs if
Calcium Channel
Blocker
FDA Pregnancy Class:
C
 Prevents passage of
calcium into cardiac &
smooth muscle that
prevents contractions
Indigestion
Nausea
Occult blood loss
Anorexia
Drowsiness
Gi bleeding
Peripheral edema
Acute renal failure
Anaphylaxis
 Shortness of
breath/difficulty breahing
 Fluid build up within ankles,
feet, and legs
 Mild hypotension
 Monitor vitals
Test patellar reflex
 Monitor newborn for
hypotension, hyporeflexia, and
respiratory depression
 Monitor intake/output levels
 Do NOT administer if mother is
hypertensive or has preeclampsia
Generic /Trade
Name
Normal
Dosage
contractions
continue
Maxe dose: 160
mg/d
15-20 mg IM
(during early
labor)
Classification
Opioid agonistantagonist analgesic
FDA Pregnancy
Category: D
Penicillin
 Used to treat high blood
pressure with pregnant
patients
 Used to prevent
premature delivery of
fetus by stopping labor
before 37 weeks of
gestation
 Serves as an agonist at
kappa opioid receptors
 Serves as antagonist at
mu opiod receptors
 Can be used as analgesia
during labor
 Helps to significantly
reduce pain when in
labor
Nubain
Oxycodone
Hydrochloride
Therapeutic Effects &
Indications
 Can stop contractions of
the uterus through the
blockage of calcium
Adult: 5-15 mg
PO q 4-6 hr
Opiod naïve (did
not take opiod
in last 30 days):
10-30 mg PO q 4
hr
Capsules: 5 mg
PO q 6 hr
Oral Solution:
10-30 mg PO q 4
hr as needed
3g via IV at start
of labor
1.5g every 4
hours up until
deliver of the
newborn
Opiod agonist
analgesic
FDA Pregnancy Class:
C
 Binds to opiate
receptors in CNS
altering the perception
and sensation of pain
 Relief of moderate to
moderately severe pain
 Used to manage pain
associated with labor
Antibiotic
FDA Pregnancy Class:
B
 Beta-lactam ring binds
to DD-transpeptidase
leading to the
prevention of cell wall
formation within the
bacteria
Adverse Effects
Nursing Care
Teachings
 Increase in blood glucose
levels
 Monitor for AE
 Do not crush meds; swallow
whole when taking
 Do not take while
breastfeeding; can be passed
into breastmilk.













In mother:
Dizziness
Headaches
Tiredness
Irregular Heartbeat
Nausea/vomiting
Loss of appetite
In Fetus
Feal bradycardia
Hypotonia
Cyanosis
Apnea
Life threatening respiratory
depression
 Only administer when benefits
significantly outweigh the risks
 Naloxone counteract effects of
Nubain on fetus
 Monitor for respiratory
depression and HR of fetus after
administration
 Inform of severe, life
threatening SE on fetus
 Nubain is a synthetic opiod,
can lead to addiction
 May be beneficial to inform
Pt of less life-threatening
options available for pain
management during labor









Bronchospasm
Cardiac arrest
Constipation
Dizziness
Drowsiness
Flushing
Respiratory arrest
Sedation
Shock
 If breastfeeding, assure Pt takes
dose 4-6 hours before next
feeding. Can cause drowsiness in
infant
 Use pediatric formulas to
determine child does for
immediate-release form
 Adjust does for elderly patients,
those with hepatic impairment
and impaired adults
 Inform Pt that may
experience constipation;
complementary laxative or
stool softener may be highly
recommended
 Is passed through breastmilk;
may be difficult to
breastfeed
o
Infant may
experience increased
tiredness
 Assess for allergies to penicillin
 Should not be administered until
labor has started
 Monitor for signs of allergic
reaction
 Assess vitals regularly to assess PP
infection
 Why medication is being
given
 Risks to fetus if med is not
administered
 Risks while breastfeeding
o
Can pass through
breastmilk and may cause
 Fever
 Vomiting
 Rash
 Allergic reactions:
 Breathing difficulty
Generic /Trade
Name
Normal
Dosage
10 mg PO from
36 weeks until
delivery
Neonates: 0.51.0 mg IM ONCE
after birth
Classification
Pharmacologic:fatsoluble vitamins
FDA Pregnancy Class:
C
Phytonadione
Therapeutic Effects &
Indications
 Administered during
labor to treat the
bacteria Group B
stretococcous
 Helps prevent GBS
transmission to fetus
 May be used to treat PP
infections
 It depresses the central
nervous system, acts as
an anticonvulsant, and
decreases frequency
and intensity of uterine
contractions.
 Used to prevent
bleeding for people who
are Vitamin K deficient
or who have blood
clotting problems
Adverse Effects
Nursing Care
 Edema with skin and throat
 Low BP
 Fainting





Upset stomach
Unusual taste
Rash
Flushing
Scleroderma-like lesions
Teachings
rash, diarrhea, or an allergic
reaction to the newborn
 Importance of informing
provider of any allergies to
penicillin
 Do not take anticoagulants while
 Look for unusual bleeding or
bruising
 Inform others tending to patient
of tendency to bleed to prevent
further trauma
 Look for signs of internal bleeding
or hypovolemic shock
 Do not take anticoagulants
while taking this drug
 Do not increase or decrease
normal vitamin K intakevia
diet without consulting your
health care provider
 If you miss a does, take it as
soon as you rememberbut
do not double up on doses
 No known issues with
breastfeeding
 Use not recommended
during pregnancy (can
cause jaundice in baby)
 If using anti-seizure
medication during
pregnancy, can be at an
increased risk of vitamin
K deficiency
Pitocin
Initial Dose: 0.5
– 1 mU/min IV
Should be
increased to 1-2
mU/min until
desired
contractions are
reached
Oxytotic Hormone
FDA Pregnancy Class:
C
 Hormone that leads to
an increase in
prostaglandins causing
uterine contractions
 Used antepartum in
order to induce labor
and cause uterine
contractions
 Used postpartum to
promote uterine
contractions to prevent
PP hemorrhaging





IrregularHR
Nausea/vomiting
Cramping/Stomach Pain
Loss of appetite
If administered
anterpartum:
 may lead to abnormal heart
rate
 breathing issues
 jaundice within the fetus
 Monitored for excessive bleeding
and irregular HR following
administration
 During labor the frequency of
contractions should be monitored
to evaluate if the amount given
may be reduced
 Patients should also be monitored
for pain due to contractions
 Pt should be informed of the
increased within the
contractions that will occur
following the administration
of Pitocin
 Contractions will induce
pain, therefore patients
should be told of options
that they have for pain relief
 Pt should also be informed of
the risks that are associated
with the induction of labor
before the medication is
administered
Generic /Trade
Name
Normal
Dosage
One tablet
taken daily PO
or as directed
by provider
Classification
Multivitamin and
mineral supplements
FDA Pregnancy Class:
B
Prenatal
Vitamin
28 weeks
gestation: 300
mcg IM
72 hours postdelivery: 300
mcg IM
Immune Globulins
FDA Pregnancy Class:
C
Rhogam
40-125 mg PO
Pharmacologic:
Antiflatulent
FDA Pregnancy
Category: C
Simethicone
Therapeutic Effects &
Indications
 Used to treat vitamin
deficiencies
 Prenatal vitamins
include folic acid that
decreases the chance of
the fetus developing
birth defects including
spina bifida
 Prenatal vitamins also
include iron that can
help prevent anemia
 Prohibits production of
ant Rh-D antibodies
which can lead to Rh
sensitization within the
mother
 Administered at 28
weeks gestation to Rh
negative mothers
 Administered again
post-partum (72 hours
following delivery) if Rh
negative mother gives
birth to Rh positive
newborn and the
mother is negative for
anti-Rh antibodies
 coalescence and
dispersion of the gas
bubbles allowing their
removal from the GI
tract as flatulence or
belching.
 Used to treat gas,
bloating, painful
pressure, fullness
 Safe to use when
breastfeeding and
pregnant
Adverse Effects
Nursing Care
 Possible allergic reactions in
some pregnant women
including swelling, hives, or
difficulty breathing
 Stomach pains
 Headaches
 Nausea
 Assess Pt and ask for any over
OTC
 Pt should be told of specific
prenatal vitamins needed bases
on their deficiencies
 Ask about allergic reactions or
adverse effects to prenatal
vitamin
 Pain at site of injection
 Fever
 Draw labs prior to administration
of Rhogam to ensure if Rh
negative and fetus is Rh positive
 Monitor following the
administration of Rhogam for
allergic reactions or AE
 Interferes with other live vaccines
 None Significant
 Does not cross placenta
 Generally safe to use during
pregnancy
 Assess for pain
Teachings
 Education on importance of
taking prenatal vitamins to
reduce the chance of birth
defects
 Encourage to start prenatal
vitamins once pregnancy has
been determined
 Consult with provider if
allergic reactions occur
 Do not take with other
vitamin supplements
 Do not take with milk
 Take with food
 Take while breastfeeding
 Why Pt is receiving Rhogam
 Warn about pain at IM site
 Inform about possible
allergic reactions
 Advise not to receive live
vaccines for 3 months
following
 Develop regular bowel habits
and exercise regularly
 Take this product by mouth,
usually after meals and at
bedtime or as directed by
your doctor.
 Swallow the capsules whole.
Generic /Trade
Name
Normal
Dosage
50 mcg/day may
lower dosage to
25 mcg/day
after 2-3 weeks
Classification
Pharmacologic:
hormones
FDA Pregnancy risk:
Category A
Synthroid
20 mg PO, 10
mg every 4-6 hr
as needed
Pharmacologic:
NSAID
FDA Pregnancy
Category: C
Toradol
1g in 10mL IV
Second dose: 1g
given within 30
min if bleeding
persists or 24
hours if
bleeding returns
Tranexamic
Acid (TXA)
Antiifibrinolytics
FDA Pregnancy Class:
B
Therapeutic Effects &
Indications
 Replacement of or
supplement to
endogenous thyroid
hormones.
 Increases metabolic rate
 Thyroid
supplementation for
hypothyroidism
 Treatment for goiters
Adverse Effects




Headache
Insomnia
Irritability
Abdominal cramps
Nursing Care
Teachings
 Assess patient pulse and BP
before and during therapy.
 Assess for tachyarrythmia and
chest pain
 May take several weeks
before they notice an
improvement in symptoms.
 Replacement therapy is to be
taken for life.
 If planning pregnancy or is
breastfeeding, notify
healthcare provider.
 Pregnancy increases thyroid
therapy.
 *does not cross placenta,
minimal amounts enter
breastmilk
 Inhibits enzyme needed
for prostaglandin
synthesis (blocks pain)
 Used for treatment of
moderate severe pain,
usually after surgery
 May adversely affect fetal
circulation and inhibit
contractions
 Increased risk of premature
closure of ductus arteriosus
 May cause temporary
infertility
 Assess for prolonged bleeding
following discontinuation
 Assess BP, may cause fluid
retention and edema
 Brand name is Toradol, has
been discontinued in the U.S.
 Generic name is ketorolac
 Synthetic opiod
 Avoid using during
pregnancy beginning at 30
weeks
 Can be passed through
breastmilk
 Inhibits enzymatic
breakdown by reducing
the binding of TPA and
plasminogen to fibrin
 Increases rishs of
neurological issues
 Can lead to unwanted blood
clots
 Diarrhea
 Vomiting
 Nausea
 Only give to patients experiencing
PP hemorrhaging
 Administer immediately
 Not to be given within 3 or more
hours of onset of hemorrhaging
 Evaluate if bleeding ceasesd;
administer another dose if not
 Monitor for signs of DVT as TXA
promotes blood clotting
 Why med is being
administered
 Inform care provider if
bleeding continues or
returns after administration
of med
 If feeling lightheaded or pain
in lower extremities, notify
care provider
 Prevents significant
blood loss in women
who are experiencing
post-partum
hemorrhaging
 Given to women who
have lost more than
500mL of blood
following vaginal
deliveries and 1000mL
of blood following Csections
Generic /Trade
Name
Normal
Dosage
4-8 mg every 8
hours
Classification
Antagonist
FDA Pregnancy Class:
B
Zofran
Therapeutic Effects &
Indications
 Blocks serotonin
(substance that causes
nausea and vomiting)
 Reduces nausea and
vomiting (morning
sickness)
Adverse Effects






Headache
Diarrhea
Constipation
Weakness
Tiredness
Dizziness
Nursing Care
Teachings
 Assess for SE/AE
 Assess for rash
 Assess for involuntary movements
 Take as directed
 Advise patient to notify
health care professional if
have symptoms of irregular
heart beat, involuntary
movement of eyes, face, or
limbs, vision loss, blurred
vision or if symptoms don’t
go away
 Safe in breastfeeding (but no
studies to prove this), Zofran
can be given to infants as
early as 1 month old
Download